Ondero_D_10Tablets_-_Pack_of_3
Ondero_D_10Tablets_-_Pack_of_3
Ondero_D_10Tablets_-_Pack_of_3
Ondero_D_10Tablets_-_Pack_of_3
Ondero_D_10Tablets_-_Pack_of_3
Ondero_D_10Tablets_-_Pack_of_3__undefined__undefined
Ondero D 10Tablets - Pack of 3

₹663

View Available Offers

Final Price inclusive of all taxes

Free Delivery

Get it delivered in 3-6 days

size

10

Product Information

Country Of Origin

India


Ideal For

Management Of Type 2 Diabetes Mellitus. Sglt2 Inhibition And Dpp-4 Inhibition For Dual-Mechanism Glycaemic Control.


Ingredients

Dapagliflozin 10Mg, Linagliptin 5Mg


Pack Of

3


Type

Tablets

Product Description

  • Key Ingredients: Each Tablet Contains Dapagliflozin 10Mg And Linagliptin 5Mg, A Combination Therapy For Managing Blood Sugar Levels In Adults With Type 2 Diabetes.
  • Product Design: Supplied In A Convenient Blister Pack Containing White, Round Tablets With Clear Marking For Easy Identification And Dose Tracking.
  • Dual Action Formula: Combines An Sglt2 Inhibitor With A Dpp-4 Inhibitor To Provide Comprehensive Glycemic Control Through Complementary Mechanisms Of Action.
  • Versatile Occasion: Designed For Once-Daily Oral Administration As Part Of A Comprehensive Diabetes Management Plan Under Medical Supervision.
  • Quality Assurance: Pharmaceutical-Grade Medication Manufactured Following Strict Quality Standards And Regulatory Guidelines For Safety And Efficacy.
  • Ideal For: Adults With Type 2 Diabetes Mellitus Requiring Combination Therapy When Diet And Exercise Alone Do Not Provide Adequate Glycemic Control.